<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03518450</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)299/2017</org_study_id>
    <nct_id>NCT03518450</nct_id>
  </id_info>
  <brief_title>Femoral Triangle Block: Early Mobilization and Postoperative Analgesia After Total Knee Arthroplasty</brief_title>
  <official_title>Early Mobilization and Postoperative Analgesia After Total Knee Arthroplasty, a Prospective Comparative Study: Adductor Canal Block vs. Femoral Nerve Block vs. Apex Femoral Triangle Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial is to compare the efficacy of three different nerve blocks as an
      analgesic option after total knee arthroplasty (TKA), based on muscle strength, mobilization
      and pain.

      The Adductor Canal Block has been proposed as an equally effective technique to the Femoral
      Nerve Block in terms of pain control after a TKA, with the benefit of preserving muscle
      function. We hypothesize that a block performed at the apex of the femoral triangle would
      best balance analgesia with quadriceps function.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum voluntary isometric contraction (MVIC)</measure>
    <time_frame>6 hours postoperatively</time_frame>
    <description>It measures quadriceps strength and is normalized to the body mass index (N * m/kg). This test correlates well with the functional outcome. Will be measured with standard handheld dynamometer (MicroFET2; Hoogan Industries, West Jordan, Utah) perpendicular to the tibial crest 5 cm proximal to the medial malleolus to make the measurement. The patients are told to &quot;reach maximum force and hold for three seconds.&quot; Three measurements will be done, and the average will be taken.
The primary effectiveness endpoints of the study will be the percentage of baselineMVIC retained on the quadriceps of the leg receiving arthroplasty for each subject at 6 hours postoperatively.
A higher the percentage will relate with less motor block.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go (TUG)</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>Timed Up and Go gauges a patient's sense of balance by measuring the time required for a certain set of movements: stand up from a chair, walk 3 m, walk back, and sit down. It has been verified to serve as a good indicator of functional level.
Measured in seconds, the better values are related to shorter times.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30' CST (30 secs Chair Stand Test)</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>How many times can a patient stand up and sit down from a chair in 30 seconds. The amount of times will be counted, more times will be related to a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion (ROM)</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>Range of motion refers to a knee's degree of extension or flexion and is measured via a goniometer. Considering normal values from 0-120º, the baseline movement will be measured preoperatively to be compared postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daniels' Test</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>Active extension of the knee against gravity and applied resistance (0-5). 5: normal contraction against gravity and maximal resistance. 0: abscence of contraction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>10-PMS (10 point Mobility Scale)</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>Scale from 0-10 in which the mobility of the patient is measured; sitting on the bed, chair, edge of the bed, mobilize the knee more than 45º, stand up, walk with or without a mobility aid.
Higher values are related to better outcomes.
An expected degree of flexion of the knee is ≥45 degrees on postoperative day 1 and ≥70 degrees on postoperative day 3.
Expected points for postoperative day 0: 4 points Expected points for postoperative day 1: 8 points Expected points for postoperative day 2: 9-10 points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain measurement trough the visual analogue scale (VAS)</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>Pain will be measured via the VAS pain score by having the patient point on an unmarked scale how their pain was and then translating it to millimeters on the 100-mm scale.
0 mm: no pain 100 mm: severe/extreme pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantity of opioids administered</measure>
    <time_frame>6, 24 and 48 hours postoperatively.</time_frame>
    <description>into morphine equivalent if needed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APS-POQ-R.</measure>
    <time_frame>At 24 hours postoperatively</time_frame>
    <description>Developed by an interdisciplinary task force of members of the American Pain Society, the Patient Outcome Questionnaire (APS-POQ) for QI has been revised to include instrument psychometrics. The article is available by open access at The Journal of Pain web site.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>24 and 48 hours postoperatively</time_frame>
    <description>Scale from 0 to 10, answering how do they feel about the treatment received, being 10 the maximum value related to the highest satisfaction level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>at patient discharge, an average of 6 days postoperatively</time_frame>
    <description>Days from surgery until discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum voluntary isometric contraction (MVIC)</measure>
    <time_frame>24 and 48 hours postoperatively.</time_frame>
    <description>It measures quadriceps strength and is normalized to the body mass index (N * m/kg). This test correlates well with the functional outcome. Will be measured with standard handheld dynamometer (MicroFET2; Hoogan Industries, West Jordan, Utah) perpendicular to the tibial crest 5 cm proximal to the medial malleolus to make the measurement. The patients are told to &quot;reach maximum force and hold for three seconds.&quot; Three measurements will be done, and the average will be taken.
The primary effectiveness endpoints of the study will be the percentage of baselineMVIC retained on the quadriceps of the leg receiving arthroplasty for each subject at 6, 24, and 48 hours postoperatively.
A higher the percentage will relate with less motor block.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <condition>Anesthesia, Conduction</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Ultrasonography, Interventional</condition>
  <arm_group>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided femoral nerve block, 30 ml of 0.25% bupivacaine and 4 mg of dexamethasone to be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adductor Canal Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided adductor canal block, at the proximal third of the canal, 30 ml of 0.25% bupivacaine and 4 mg of dexamethasone to be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Apex Femoral Triangle Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided femoral triangle block, at the distal third of the triangle, 30 ml of 0.25% bupivacaine and 4 mg of dexamethasone to be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Apex Femoral Triangle Block</intervention_name>
    <description>Nerve block that aims the vastus medialis nerve, the saphenous nerve and the anterior femoral cutaneous nerve.</description>
    <arm_group_label>Apex Femoral Triangle Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Femoral Nerve Block</intervention_name>
    <description>Regional anesthetic technique that blocks the sensory and motor information of the femoral nerve (and it's branches).</description>
    <arm_group_label>Femoral Nerve Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor Canal Block</intervention_name>
    <description>Interfascial block that targets mainly the saphenous nerve.</description>
    <arm_group_label>Adductor Canal Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects of any gender, from 18 to 90 years old that accept to participate in the
             study.

          -  Programmed primary total knee arthroplasty surgery

        Exclusion Criteria:

          -  Emergent surgery

          -  Reinterventions

          -  Unstable psychiatric pathology, dementia

          -  Kidney or hepatic disease that contraindicates the use of NSAIDs and/or Paracetamol.

          -  Allergy to amides local anesthesics, NSAIDs, opioids and/or Paracetamol.

          -  Daily use of opioids greater than 30 mg of morphine (or equivalent)

          -  Patients under 18 or over 90 years old.

          -  Drug abuse

          -  Rejection to be a participant of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfons Biarnes Suñe, M.D., Ph.D.</last_name>
    <role>Study Director</role>
  </overall_official>
  <overall_contact>
    <last_name>Carlos I Salvadores de Arzuaga, M.D.</last_name>
    <phone>+34646748871</phone>
    <email>csalvadores@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alfons Biarnes Suñe, M.D., Ph.D.</last_name>
    <email>abiarnes@vhebron.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos I Salvadores de Arzuaga, M.D.</last_name>
      <phone>+34646748871</phone>
      <email>csalvadores@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Carlos I Salvadores de Arzuaga, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfons Biarnes Suñe, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oscar Salmeron Zafra, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José M Naya Sieiro, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea S Khoudeir Avila, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleix Pons Bartroli, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcos de Miguel Negro, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel A González Posada, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María I Rochera Villach, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcelo A García, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Judith Sanchez Raya, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Enric Castellet Feliu, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nayana Joshi Jubert, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cindy E Mokund González, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esther Marquez Martinez, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eladio Lucas Sanjorge, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Danninger T, Opperer M, Memtsoudis SG. Perioperative pain control after total knee arthroplasty: An evidence based review of the role of peripheral nerve blocks. World J Orthop. 2014 Jul 18;5(3):225-32. doi: 10.5312/wjo.v5.i3.225. eCollection 2014 Jul 18. Review.</citation>
    <PMID>25035824</PMID>
  </reference>
  <reference>
    <citation>Dong CC, Dong SL, He FC. Comparison of Adductor Canal Block and Femoral Nerve Block for Postoperative Pain in Total Knee Arthroplasty: A Systematic Review and Meta-analysis. Medicine (Baltimore). 2016 Mar;95(12):e2983. doi: 10.1097/MD.0000000000002983. Review.</citation>
    <PMID>27015172</PMID>
  </reference>
  <reference>
    <citation>Paul JE, Arya A, Hurlburt L, Cheng J, Thabane L, Tidy A, Murthy Y. Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology. 2010 Nov;113(5):1144-62. doi: 10.1097/ALN.0b013e3181f4b18. Review.</citation>
    <PMID>20966667</PMID>
  </reference>
  <reference>
    <citation>Chelly JE, Greger J, Gebhard R, Coupe K, Clyburn TA, Buckle R, Criswell A. Continuous femoral blocks improve recovery and outcome of patients undergoing total knee arthroplasty. J Arthroplasty. 2001 Jun;16(4):436-45.</citation>
    <PMID>11402405</PMID>
  </reference>
  <reference>
    <citation>Sharma S, Iorio R, Specht LM, Davies-Lepie S, Healy WL. Complications of femoral nerve block for total knee arthroplasty. Clin Orthop Relat Res. 2010 Jan;468(1):135-40. doi: 10.1007/s11999-009-1025-1. Epub 2009 Aug 13.</citation>
    <PMID>19680735</PMID>
  </reference>
  <reference>
    <citation>Burckett-St Laurant D, Peng P, Girón Arango L, Niazi AU, Chan VW, Agur A, Perlas A. The Nerves of the Adductor Canal and the Innervation of the Knee: An Anatomic Study. Reg Anesth Pain Med. 2016 May-Jun;41(3):321-7. doi: 10.1097/AAP.0000000000000389.</citation>
    <PMID>27015545</PMID>
  </reference>
  <reference>
    <citation>Abdallah FW, Whelan DB, Chan VW, Prasad GA, Endersby RV, Theodoropolous J, Oldfield S, Oh J, Brull R. Adductor Canal Block Provides Noninferior Analgesia and Superior Quadriceps Strength Compared with Femoral Nerve Block in Anterior Cruciate Ligament Reconstruction. Anesthesiology. 2016 May;124(5):1053-64. doi: 10.1097/ALN.0000000000001045.</citation>
    <PMID>26938989</PMID>
  </reference>
  <reference>
    <citation>Elkassabany NM, Antosh S, Ahmed M, Nelson C, Israelite C, Badiola I, Cai LF, Williams R, Hughes C, Mariano ER, Liu J. The Risk of Falls After Total Knee Arthroplasty with the Use of a Femoral Nerve Block Versus an Adductor Canal Block: A Double-Blinded Randomized Controlled Study. Anesth Analg. 2016 May;122(5):1696-703. doi: 10.1213/ANE.0000000000001237.</citation>
    <PMID>27007076</PMID>
  </reference>
  <reference>
    <citation>Wong WY, Bjørn S, Strid JM, Børglum J, Bendtsen TF. Defining the Location of the Adductor Canal Using Ultrasound. Reg Anesth Pain Med. 2017 Mar/Apr;42(2):241-245. doi: 10.1097/AAP.0000000000000539.</citation>
    <PMID>28002228</PMID>
  </reference>
  <reference>
    <citation>Kardash KJ, Noel GP. The SPANK Block: A Selective Sensory, Single-Injection Solution for Posterior Pain After Total Knee Arthroplasty. Reg Anesth Pain Med. 2016 Jan-Feb;41(1):118-9. doi: 10.1097/AAP.0000000000000330.</citation>
    <PMID>26678763</PMID>
  </reference>
  <reference>
    <citation>Jaeger P, Nielsen ZJ, Henningsen MH, Hilsted KL, Mathiesen O, Dahl JB. Adductor canal block versus femoral nerve block and quadriceps strength: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Anesthesiology. 2013 Feb;118(2):409-15. doi: 10.1097/ALN.0b013e318279fa0b.</citation>
    <PMID>23241723</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Børglum J. The Optimal Analgesic Block for Total Knee Arthroplasty. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):711-719.</citation>
    <PMID>27685346</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2018</study_first_posted>
  <last_update_submitted>May 5, 2018</last_update_submitted>
  <last_update_submitted_qc>May 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

